Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the analytical validation of NavDx+Gyn, an important extension of the NavDx® blood test.

The human papillomavirus or HPV vaccination program has reportedly achieved herd immunity according to research conducted at ...

Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the analytical validation of NavDx+Gyn, an important extension of the NavDx® blood test.

HPV infection increases cardiovascular disease risk by 40% and doubles coronary artery disease risk, adding to concerns about ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Cancer caused by the common human papillomavirus infection, also known as HPV, is increasing in some women in the U.S., ...

In addition to causing several types of cancer, human papillomavirus (HPV) appears to bring a significantly increased risk of heart disease and coronary artery disease, according to a study being ...

HPV, a virus already known for causing several cancers, is now being linked to a significantly increased risk of heart ...

An Ohio State University study finds that many people lack crucial information about human papillomavirus transmission and ...

The HPV vaccine, called Gardasil-9 — which has no live virus and is completely non-infectious — protects against the six types of HPV most likely to cause cancer, Eckert says. (These are strains 6, 11 ...

Cervical cancer is one of the most preventable cancers with the HPV vaccine. Recent research suggests that the U.S. is ...